IO Biotech
IOBT
IOBT
15 hedge funds and large institutions have $24M invested in IO Biotech in 2023 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
40% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 5
Holders
15
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$205K | |
| 2 | +$85.5K | |
| 3 | +$85.5K | |
| 4 |
Morgan Stanley
New York
|
+$50.3K |
| 5 |
TSS
Two Sigma Securities
New York
|
+$25.5K |
Top Sellers
| 1 | -$2.63M | |
| 2 | -$783K | |
| 3 | -$92.3K | |
| 4 |
Millennium Management
New York
|
-$37K |
| 5 |
CC
Cannell Capital
Alta,
Wyoming
|
-$23.6K |